Please upgrade your browser.
Retrospective and prospective study in mRCC patients treated with sutent in first line and rechallenged by Sutent in 3rd and 4th line.
Tumors gain survival advantage by reprogramming their metabolism according to an international team of scientists, led by UC Davis nephrologist Robert Weiss...
Final results now show a median PFS in this setting of 11.0 months and median overall survival (OS) of 21.6 months, demonstrating the efficacy of tivozanib in a VEGF treatment refractory population.
Current and former smokers have more complications from major surgery for some urology-related cancers, according to new research.
The Kidney Cancer Association has reached out to Seattle Seahawks reserve defensive tackle Jesse Williams who will undergo surgery after being diagnosed with kidney cancer.
Abstracts in genitourinary cancers, including: Changes in treatment patterns among patients receiving at least two targeted therapies for metastatic renal cell carcinoma (mRCC) in the US...
An aggressive form of kidney cancer subsides in mice when researchers block the metabolism of an amino acid called glutamine, a new study shows.
Gene Evaluation of DNA expression from snap-frozen renal cell cancer tissue from 5 patients with locally advanced non-metastatic tumors, submitted to nephrectomy after being treated with 2 cycles of neoadjuvant Sunitinib...
Supported by Kidney Cancer Association.Matthew T. Campbell, MD The University of Texas MD Anderson Cancer Center “Enhancing therapeutic efficacy in metastatic renal cell carcinoma by combining immune check point blockade with cryoablation”
Ethical Issues in the Management of RCC, including informed consent, disclosure of physician experience, and more.
|Powered by NeonCRM|